Patent details

Basic Information

Publication number:

EP2335719

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP101961399

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Use of hemojuvelin fusion proteins to regulate hepcidin-mediated iron metabolism

French Title of Invention:

Utilisation de protéines de fusion de l'hémojuvéline pour réguler le métabolisme du fer regulé par l'hepcidine

German Title of Invention:

Verwendung von Hemojuvelin Fusionproteinen zur Behandlung von Hepcidin-reguliertem Eisenmetabolismus

SPC Number:

Dates

Filing date:

16/02/2006

Grant date:

24/06/2015

EP Publication Date:

24/06/2015

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

22/06/2011

EP B1 Publication Date:

24/06/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

16/02/2016

Expiration date:

16/02/2026

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

16/02/2006

 

 

Name:

The General Hospital Corporation

Address:

55 Fruit Street, Boston, MA 02114, United States (US)

Inventor

1

Name:

Schneyer Alan, L.

Address:

United States (US)

2

Name:

Babitt Jodie

Address:

United States (US)

3

Name:

Woolf Clifford

Address:

United States (US)

4

Name:

Lin Herbert Y

Address:

United States (US)

5

Name:

Chung Raymond T

Address:

United States (US)

6

Name:

Samad Tarek, A.

Address:

United States (US)

Priority

Priority Number:

653479 P

Priority Date:

16/02/2005

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 38/17;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages